The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Investors tread carefully ahead of record highs

Wed, 28th May 2014 17:18

- Eurozone money supply weak, German unemployment rises - Markets cautious after recent highs- LSE leads financials higher- GSK to be investigated by UK fraud bodytechMARK 2,799.81 +0.48%FTSE 100 6,851.22 +0.09%FTSE 250 15,935.43 +0.58%UK stocks ended slightly higher after trading in a narrow range throughout most of the Wednesday as investors showed caution given global indices were at multi-year or record highs and amid weak macroeconomic data out on the Continent.So-called 'broad' money supply in the Eurozone eased to a year-on-year rate of 0.8% in April, versus the 1.1% which analysts had penciled in. "The continuation of the downward trend in money supply (M3) growth to levels not seen since the immediate aftermath of the global financial crisis and weak April bank lending figures for households and non-financial firms significantly increase the likelihood that the ECB is going to announce further targeted liquidity measures on June 5th," Barclays Research wrote to clients. The FTSE 100 ended the session just 0.1% higher at 6,851.22.For her part, Chief Market Strategist Brenda Kelly from IG said that the weak German unemployment figures earlier in the day had "cast a pall over markets, and a day devoid of further major macro has meant markets are struggling for direction".As an aside, the euro spent much of the day skirting the 1.36 mark.Acting as a backdrop, in the afternoon Reuters quoted a NATO military officer as having stated that while Russian troops may indeed be slowly pulling back from the border with Ukraine the bulk of the force remains close to it for now.In parallel, overnight the Governor of the central bank of China Zhou Xiaochuan said the economy is in a rare "complicated" situation amid speculation policymakers will introduce new measures to spur growth in the world's second largest economy.London real estate heading for natural correctionThe Confederation of British Industry's (CBI) distributives trades survey revealed a slowdown in the pace of retail sales growth in the UK during the month of May. The total sales index retreated to a reading of 16, whereas economists had been expecting a reading of 35.For its part, London real estate is heading for a "natural correction", according to building society Nationwide, which released its results on Wednesday.Volatility spike in Smith&Nephew sharesSmith & Nephew shares experienced a spike in volatility in afternoon trading on the back of reports - later denied by the ostensible suitor itself - that US medical device manufacturer Stryker was readying a takeover offer.Stock exchange operator LSE was also in demand after Credit Suisse said it expects a re-rating of the stock over time if the possible acquisition of Russell Investments is completed. The bank added LSE to its 'Focus List' and kept an 'outperform' rating.Cantor Fitzgerald reiterated its 'sell' rating on Royal Mail, and cut its target price from 500p to 480p, pushing the stock into the bottom spot.Meanwhile, BT Group benefited from an upbeat outlook from Goldman Sachs, which said the stock offers higher growth and a cheaper valuation than others in the sector. Goldman added that it is upbeat about the telecom's upcoming launch of consumer mobile operations later this year.Shares in GlaxoSmithKline declined on the news that the Serious Fraud Office has opened a criminal investigation into the "commercial practices" at the pharmaceutical group. The news came as a further blow to shareholders after a wave of bribery allegations against the company in recent months.Broker Shore Capital downgraded its 2015 and medium-term forecasts and said its neutral recommendation for Marks & Spencer, "may be so for quite a while". Analyst Clive Black is now looking for modest year-on-year growth of around 3% for 2015 earnings per share of 33.5p, a 4% downgrade. He forecasts a free cash flow yield of 7.5% for next year, with a dividend yield of 3.9%.As a group shares in miners, such as Anglo American, Rio Tinto and BHP Billiton were lower by the close of trading following data which showed that Chinese industrial profits increased 10% this year through April from the same period in 2013, marking a slight slowdown on the previous three months. Overnight Chinese central bank Governor Zhou Xiaochuan said the economy is in a rare "complicated" situation amid speculation policymakers will introduce new measures to spur growth in the world's second largest economy.Banknote printer De La Rue jumped after reporting a 43% surge in annual underlying operating profit and said it entered the new financial year with a good order book.A host of stocks traded lower after going ex-dividend this morning, including heavyweights Marks & Spencer and Whitbread. Amec, Bellway, Britvic, Cable & Wireless Communications, Premier Farnell and Spectris also went ex-dividend today.FTSE 100 - RisersSmith & Nephew (SN.) 993.50p +4.25%London Stock Exchange Group (LSE) 1,955.00p +2.57%Hargreaves Lansdown (HL.) 1,216.00p +2.18%Barratt Developments (BDEV) 368.90p +2.16%Rolls-Royce Holdings (RR.) 1,016.00p +1.80%Severn Trent (SVT) 1,933.00p +1.79%BT Group (BT.A) 398.40p +1.63%ITV (ITV) 184.60p +1.60%HSBC Holdings (HSBA) 629.20p +1.29%William Hill (WMH) 346.30p +1.23%FTSE 100 - FallersRoyal Mail (RMG) 516.00p -2.73%Anglo American (AAL) 1,527.50p -1.89%Rio Tinto (RIO) 3,177.50p -1.81%GlaxoSmithKline (GSK) 1,608.50p -1.59%Marks & Spencer Group (MKS) 443.60p -1.58%easyJet (EZJ) 1,565.00p -1.45%BHP Billiton (BLT) 1,922.00p -1.31%Sainsbury (J) (SBRY) 335.50p -1.03%Diageo (DGE) 1,880.50p -1.03%Carnival (CCL) 2,393.00p -0.99%FTSE 250 - RisersDe La Rue (DLAR) 874.00p +7.90%Ocado Group (OCDO) 366.40p +6.33%SIG (SHI) 196.20p +5.48%Kier Group (KIE) 1,710.00p +4.97%QinetiQ Group (QQ.) 205.50p +4.37%Kazakhmys (KAZ) 276.40p +4.30%Hikma Pharmaceuticals (HIK) 1,683.00p +4.21%Laird (LRD) 297.00p +4.10%Serco Group (SRP) 369.40p +4.06%Kentz Corporation Ltd. (KENZ) 734.00p +3.82%FTSE 250 - FallersCable & Wireless Communications (CWC) 53.40p -3.78%Rightmove (RMV) 2,262.00p -3.33%Bwin.party Digital Entertainment (BPTY) 117.40p -3.22%Amec (AMEC) 1,174.00p -2.57%Evraz (EVR) 103.80p -2.54%Barr (A.G.) (BAG) 623.50p -2.43%Moneysupermarket.com Group (MONY) 170.00p -2.19%Marston's (MARS) 151.10p -2.14%Inchcape (INCH) 624.50p -2.04%Entertainment One Limited (ETO) 296.50p -1.79%AB
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.